| |
| |
|
| Insider
Information: |
Bunker Kevin D. |
| Relationship: |
Chief Scientific Officer |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
834,931 |
|
|
Indirect Shares
|
15,350 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
850,281 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zentalis Pharmaceuticals, Llc |
ZNTL |
Chief Scientific Officer |
2023-12-20 |
834,931 |
2023-12-20 |
15,350 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2023-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
24,158 |
834,931 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2023-10-04 |
4 |
AS |
$19.43 |
$118,355 |
D/D |
(6,068) |
859,089 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2023-05-26 |
4 |
AS |
$30.02 |
$2,401,248 |
I/I |
(80,000) |
15,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2023-02-14 |
4 |
AS |
$19.98 |
$129,873 |
D/D |
(6,500) |
865,157 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2023-02-13 |
4 |
AS |
$20.42 |
$77,756 |
D/D |
(3,807) |
871,657 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
91,354 |
875,464 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2022-11-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
784,110 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Scientific Officer |
• – – |
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
814,110 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-08-10 |
4 |
AS |
$30.00 |
$150,000 |
I/I |
(5,000) |
95,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-07-20 |
4 |
AS |
$30.00 |
$150,000 |
I/I |
(5,000) |
100,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-07-14 |
4 |
AS |
$30.01 |
$98,721 |
I/I |
(3,290) |
105,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-07-13 |
4 |
AS |
$30.02 |
$51,341 |
I/I |
(1,710) |
108,290 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-07-05 |
4 |
AS |
$30.07 |
$751,653 |
I/I |
(25,000) |
110,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-04-11 |
4 |
AS |
$30.37 |
$152,745 |
I/I |
(5,000) |
135,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-03-21 |
4 |
AS |
$48.72 |
$490,670 |
I/I |
(10,000) |
140,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-03-10 |
4 |
AS |
$46.23 |
$469,374 |
I/I |
(10,000) |
150,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-02-22 |
4 |
AS |
$47.08 |
$490,933 |
I/I |
(10,000) |
160,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-02-14 |
4 |
AS |
$50.16 |
$235,638 |
D/D |
(4,688) |
764,110 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-02-10 |
4 |
AS |
$52.15 |
$534,995 |
I/I |
(10,000) |
170,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
22,481 |
768,798 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-01-20 |
4 |
AS |
$59.17 |
$599,912 |
I/I |
(10,000) |
180,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2022-01-10 |
4 |
AS |
$67.24 |
$684,097 |
I/I |
(10,000) |
190,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2021-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,750 |
746,317 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2021-12-20 |
4 |
AS |
$77.45 |
$792,431 |
I/I |
(10,000) |
200,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Operating Officer |
• – – |
2021-12-10 |
4 |
AS |
$70.29 |
$717,106 |
I/I |
(10,000) |
210,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
